Efficacy and Tolerability of Aliskiren/Amlodipine Single-Pill Combinations in Hypertensive Patients Who did not Respond Fully to Amlodipine Monotherapy: An 8-Week, Randomized, Double-Blind Study

被引：0
|
作者：
Pfeiffer, Dietrich [1 ]
Rennie, Nicola [2 ]
Papst, Cheraz Cherif [2 ]
Zhang, Jack [3 ]
机构：
[1] Univ Leipzig, Dept Cardiol & Angiol, Leipzig, Germany
[2] Novartis Pharma AG, Basel, Switzerland
[3] Novartis Pharmaceut, E Hanover, NJ USA
来源：
HYPERTENSION | 2011年 / 58卷 / 05期
关键词：
Aliskiren Amlodipine hypertension;
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E119 / E120
页数：2
相关论文
共 50 条
  • [31] An 18-Week, Prospective, Randomized, Double-Blind, Multicenter Study of Amlodipine/Ramipril Combination Versus Amlodipine Monotherapy in the Treatment of Hypertension: The Assessment of Combination Therapy of Amlodipine/Ramipril (ATAR) Study
    Miranda, Roberto Dischinger
    Mion, Decio, Jr.
    Rocha, Joao Carlos
    Kohlmann, Oswaldo, Jr.
    Mota Gomes, Marco Antonio
    Kerr Saraiva, Jose Francisco
    Amodeo, Celso
    Luna Filho, Braulio
    CLINICAL THERAPEUTICS, 2008, 30 (09) : 1618 - 1628
  • [32] Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: amulticenter, randomized, double-blind, controlled trial
    Mourad, Jean-Jacques
    Amodeo, Celso
    de Champvallins, Martine
    Brzozowska-Villatte, Romualda
    Asmar, Roland
    JOURNAL OF HYPERTENSION, 2017, 35 (07) : 1481 - 1495
  • [33] Efficacy and Tolerability of Olmesartan Medoxomil Combined with Amlodipine in Patients with Moderate to Severe Hypertension after Amlodipine MonotherapyA Randomized, Double-Blind, Parallel-Group, Multicentre Study
    Massimo Volpe
    Peter Brommer
    Uwe Haag
    Cristina Miele
    Clinical Drug Investigation, 2009, 29 : 11 - 25
  • [34] Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
    Zhang, Shuyang
    Li, Ying
    Xu, Xin
    Xu, Rui
    Zhang, Linchao
    Wan, Xiaoqun
    Yao, Zhuhua
    Sun, Yuemin
    Liu, Yong
    Bin, Jianping
    Wang, Zhen
    Li, Shuren
    Yang, Ping
    Xu, Xiping
    Liang, Weidong
    Gao, Xiaohong
    Li, Xiaodong
    Jia, Min
    Ma, Guang
    Gu, Xiang
    Hong, Chang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [35] Evaluation of the Dose-Response Relationship of Amlodipine and Losartan Combination in Patients with Essential HypertensionAn 8-Week, Randomized, Double-Blind, Factorial, Phase II, Multicenter Study
    Chang-Gyu Park
    Ho-Joong Youn
    Shung-Chull Chae
    Joo-Young Yang
    Moo-Hyun Kim
    Taek-Jong Hong
    Cheol Ho Kim
    Jae Joong Kim
    Bum-Kee Hong
    Jin-Won Jeong
    Si-Hoon Park
    Jun Kwan
    Young-Jin Choi
    Seung-Yun Cho
    American Journal of Cardiovascular Drugs, 2012, 12 : 35 - 47
  • [36] Evaluation of the Dose-Response Relationship of Amlodipine and Losartan Combination in Patients with Essential Hypertension An 8-Week, Randomized, Double-Blind, Factorial, Phase II, Multicenter Study
    Park, Chang-Gyu
    Youn, Ho-Joong
    Chae, Shung-Chull
    Yang, Joo-Young
    Kim, Moo-Hyun
    Hong, Taek-Jong
    Kim, Cheol Ho
    Kim, Jae Joong
    Hong, Bum-Kee
    Jeong, Jin-Won
    Park, Si-Hoon
    Kwan, Jun
    Choi, Young-Jin
    Cho, Seung-Yun
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2012, 12 (01) : 35 - 47
  • [37] The combination of olmesartan medoxomil and Amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study
    Chrysant, Steven G.
    Melino, Michael
    Karki, Sulekha
    Lee, James
    Heyrman, Reinilde
    CLINICAL THERAPEUTICS, 2008, 30 (04) : 587 - 604
  • [38] A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy
    Eun-Seok Jeon
    Sang Wook Lim
    Seok-Yeon Kim
    Hyoung-Mo Yang
    Moo Hyun Kim
    Moo-Yong Rhee
    Seung Hwan Han
    Jinho Shin
    Kwang-il Kim
    Jin-Ok Jeong
    Ki Chul Sung
    Geu Ru Hong
    Hyung-Seop Kim
    Kihwan Kwon
    Tae-Soo Kang
    Hae-Young Lee
    Su-Eun Han
    Clinical Hypertension, 28
  • [39] A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy
    Jeon, Eun-Seok
    Lim, Sang Wook
    Kim, Seok-Yeon
    Yang, Hyoung-Mo
    Kim, Moo Hyun
    Rhee, Moo-Yong
    Han, Seung Hwan
    Shin, Jinho
    Kim, Kwang-il
    Jeong, Jin-Ok
    Sung, Ki Chul
    Hong, Geu Ru
    Kim, Hyung-Seop
    Kwon, Kihwan
    Kang, Tae-Soo
    Lee, Hae-Young
    Han, Su-Eun
    CLINICAL HYPERTENSION, 2022, 28 (01)
  • [40] Efficacy and Tolerability of Telmisartan/Amlodipine plus Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI Study
    Sung, Ki-Chul
    Oh, Yong-Seog
    Cha, Dong-Hun
    Hong, Soon-Jun
    Won, Kyung-Heon
    Yoo, Ki-Dong
    Rha, Seung-Woon
    Ahn, Young-Keun
    Ahn, Jeong-Cheon
    Jang, Ji-Yong
    Hong, Tack-Jong
    Cho, Sang-Kyoon
    Park, Sang-Ho
    Hyon, Min-Su
    Nam, Chang-Wook
    Chae, In-Ho
    Yoo, Byung-Su
    Song, Jong-Min
    Jeong, Jin-Ok
    Yoon, Young Won
    Kim, Byung-Soo
    Yang, Tae-Hyun
    Cho, Deok-Kyu
    Kim, Sang-Hyun
    Choi, Yu-Jeong
    Ahn, Ji-Hun
    Jeon, Dong-Woon
    Kim, Hyo-Soo
    CLINICAL THERAPEUTICS, 2018, 40 (01) : 50 - 63
12345